Protein Phosphorylation Ancillary Study to Amgen Protocol 20060104: Open Label Study to Assess the Safety and Immunogenicity of Etanercept SFP When Administered to Subjects Diagnosed With Rheumatoid Arthritis
Latest Information Update: 12 Aug 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Amgen
- 12 Aug 2016 New trial record